Anschutz Cancer Pavilion
Aurora, Colorado 80045
1 studies enrolling now · 15 studies all time
What they study most
Advanced Cancer, Advanced Solid Tumor, Breast Neoplasms, Fallopian Tube Cancer, Fallopian Tube Neoplasms, Gynecologic Cancer, Melanoma, Metastases, Metastatic Pancreatic Ductal Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type
Studies at this site
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
- Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients — Stopped early
- A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients — Completed
- Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC. — Stopped early
- A Study Of PF-04449913 Administered Alone In Select Solid Tumors — Completed
- A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC — Status unconfirmed
- A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor — Paused
- Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC — Completed
- Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer — Completed
- A Trial In Patients With Advanced Cancer And Leukemia — Completed
- Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer — Stopped early
- A Study Of PF-06664178 In Patients With Advanced Solid Tumors — Stopped early
- MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism — Completed